Barbiturate dependence is a long‑term condition where the body and brain adapt to barbiturates and begin to rely on them. People with barbiturate dependence often feel strong cravings and may have anxiety, sleep problems, or mood changes without the drug. Overdose and withdrawal can be dangerous and may be life threatening, especially if stopped suddenly or mixed with alcohol or opioids. It can affect teens and adults, and risk rises with frequent or long‑term use. Treatment usually includes medically supervised detox, counseling, and sometimes medicines to ease withdrawal and support recovery.
Overview
Barbiturate dependenceSymptoms
Barbiturate dependence often shows as strong cravings, needing higher doses, and using despite harm. Early symptoms of barbiturate dependence include daytime sleepiness, poor coordination, and memory slips. Withdrawal brings anxiety, shaking, trouble sleeping, nausea, and, rarely, seizures.
Outlook and prognosis
Many people living with barbiturate dependence improve with a steady plan: slow, medically guided tapering, counseling, and support for sleep or anxiety. Early treatment lowers risks like seizures, memory problems, and overdose. Long-term recovery is realistic, though relapses can occur and need prompt care.
Causes and risk factors
Barbiturate dependence can follow prolonged use, rapid-acting pills, or mixing with alcohol. Risk rises with genetic vulnerability, family history, other substance use, mental health issues, high stress, and easy access; watch for early symptoms of barbiturate dependence.
Genetic influences
Genetics plays a modest role in barbiturate dependence. Variations in genes affecting brain receptors and drug metabolism can raise or lower risk, tolerance, and withdrawal severity. Still, environment, mental health, and exposure usually drive most vulnerability.
Diagnosis
Diagnosis of Barbiturate dependence is clinical: providers ask about use patterns, loss of control, and withdrawal symptoms. They may perform an exam and mental health screening, and order urine or blood tests for barbiturates. Other causes are ruled out.
Treatment and drugs
Treatment for barbiturate dependence focuses on safe withdrawal, relapse prevention, and rebuilding daily functioning. Care often includes a slow, medically supervised taper, monitoring for seizures, and support with counseling, cognitive behavioral therapy, and peer groups. Some benefit from sleep, mood, or anxiety treatments while the brain recalibrates.
Symptoms
People often notice changes in energy, mood, and sleep alongside a growing pull to take the medicine more often. Early symptoms of barbiturate dependence may include needing higher doses to get the same calming effect and feeling unwell when a dose is late. Symptoms vary from person to person and can change over time. Over time, these patterns can affect work, relationships, and safety.
Over time, the same dose no longer calms or helps you sleep as it once did. This is tolerance, and it often leads people to take higher doses in barbiturate dependence.
Urges to use can feel persistent, especially under stress or before bedtime. Many find themselves planning their day around pills or refills in barbiturate dependence.
You may take larger amounts or use for longer than you meant to. Attempts to cut back don’t stick, even with good intentions.
When doses are late or missed, anxiety, shaking, sweating, nausea, and trouble sleeping can appear. Severe withdrawal can bring confusion or seizures and needs urgent medical care.
How people usually first notice Barbiturate dependence?
Many people first notice barbiturate dependence when a “needed” pill for sleep or anxiety becomes a habit, and skipping a dose triggers rebound symptoms like jitteriness, restlessness, or trouble sleeping. Over time, they may realize they need higher doses for the same effect (tolerance), or feel early withdrawal—anxiety, tremor, sweating, nausea, or a fast heartbeat—if they delay a dose, which can be a key first sign of barbiturate dependence. Some notice concerning patterns others point out, like memory lapses, daytime drowsiness, slowed thinking, or risky use (mixing with alcohol), especially when attempts to cut back are difficult.
Types of Barbiturate dependence
Barbiturate dependence can look different from person to person depending on the specific drug used, dose, and how long someone has been taking it. Broadly, symptoms are grouped into patterns tied to how the body adapts to barbiturates over time and how it reacts when levels drop. People may notice different sets of symptoms depending on their situation. When reading about types of Barbiturate dependence, keep in mind that early symptoms of Barbiturate dependence can be subtle and then gradually intensify.
Acute intoxication–dominant
The main issues happen while the drug is active, with heavy sedation, slowed thinking, slurred speech, and poor coordination. Falls, slowed breathing, and risk to driving or operating machinery are common. Memory gaps around events can occur.
Tolerance and dose escalation
Over time the same dose does less, so people take more to get the same effect. This raises overdose risk and deepens sedation and cognitive fog. Cravings and spending more time obtaining or using the drug can grow.
Withdrawal‑predominant pattern
Symptoms surge when doses are cut or missed, including anxiety, tremor, sweating, nausea, and trouble sleeping. In more severe cases, seizures, hallucinations, or dangerously fast heart rate can occur. Medical supervision is often needed to taper safely.
Mixed pattern with alcohol or benzodiazepines
Using barbiturates alongside other downers compounds sedation and breathing suppression. Dependence can involve multiple substances, and withdrawal may be more complex. Loved ones may recognize certain types sooner than the person experiencing them.
Comorbid mental health focus
Some rely on barbiturates to self-manage anxiety, insomnia, or mood symptoms. Dependence can mask or worsen these conditions over time. Treating both the substance use and the underlying condition improves outcomes.
Functional/hidden dependence
Day-to-day routines continue, but use is frequent and increasing, with secretive refills or doctor shopping. People may appear merely tired or irritable while experiencing cravings and early morning or late-day dosing to stave off withdrawal. Keeping track of which type you experience most can help guide care and taper planning.
What genetics can tell you about symptoms
Certain gene differences in liver enzymes, like CYP2C19 and CYP2B6, can slow barbiturate breakdown, leading to stronger sedation, slowed breathing, memory problems, and higher dependence risk. Variants in GABA-related genes may heighten tolerance, causing withdrawal anxiety, tremors, and seizures.
Causes and risk factors
Regular or high-dose use of barbiturates can trigger brain changes that lead to Barbiturate dependence. Longer courses, fast-acting types, and mixing with alcohol or opioids are common risk factors for Barbiturate dependence. Family history of addiction and inherited differences in how your body processes drugs can raise susceptibility. Anxiety, depression, chronic pain, sleep problems, and stressful environments can increase risk. Having risk factors doesn’t mean you’ll definitely develop the condition.
Environmental and biological risk factors
Barbiturate dependence often develops through repeated medical exposure to sedatives and the settings in which they’re used. Doctors often group risks into internal (biological) and external (environmental). Understanding these patterns can help you recognize early symptoms of barbiturate dependence sooner. Below are key environmental and biological elements linked to higher risk.
Extended use, especially beyond a few weeks, can lead to tolerance and physical dependence. The longer treatment continues, the higher the chance of barbiturate dependence. Clinicians may monitor duration closely.
Medicines that reach the brain quickly tend to feel more intense. This can increase reinforcing effects and raise the risk of barbiturate dependence. These products are linked with higher misuse potential.
Larger daily or cumulative doses drive stronger brain adaptation. As dose climbs, barbiturate dependence becomes more likely. Risk rises with both strength and frequency.
Taking barbiturates with other sedating prescriptions can amplify sedation. This combination raises the likelihood of barbiturate dependence. It can also mask early warning signs of overuse.
Genetic risk factors
Genetics play a meaningful role in who develops barbiturate dependence. Inherited differences can affect how the brain responds to these medicines and how quickly the body clears them, shaping sensitivity, tolerance, and withdrawal risk. Risk is not destiny—it varies widely between individuals. A family pattern of substance use problems can point to a higher inherited vulnerability.
Family history: Having close relatives with barbiturate dependence or other substance use disorders suggests a higher inherited risk. Shared genes can influence sensitivity to sedatives and the ease with which dependence develops.
Polygenic background: Most risk comes from many small genetic differences that add up. Together they can nudge brain circuits that control reward, stress, and self-control, making barbiturate dependence more likely in some people.
GABA receptor genes: Variants in genes that shape GABA receptors can change how strongly barbiturates calm the brain. These differences can shape early symptoms of barbiturate dependence, such as stronger sedation or faster tolerance. They may also affect withdrawal intensity.
Drug metabolism genes: Differences in liver enzymes can slow or speed how barbiturates are broken down. Slower clearance may raise blood levels and exposure time, increasing chances of barbiturate dependence and harder withdrawal. Faster clearance can shorten effects, which may accelerate tolerance and raise risk.
Dopamine signaling genes: Genetic differences in the brain’s reward pathways can influence how reinforcing sedatives feel. This broad addiction vulnerability can extend to barbiturate dependence.
Stress response genes: Variants that tune stress hormones and arousal systems can affect craving and withdrawal severity with sedatives. These inherited differences may make barbiturate dependence more likely and withdrawal more uncomfortable.
Shared mental health genetics: Some gene patterns tied to anxiety, insomnia, or depression also overlap with sedative dependence risk. This shared biology can increase the likelihood of barbiturate dependence.
Lifestyle risk factors
Barbiturate dependence often grows from patterns of use that begin as coping strategies. The lifestyle risk factors for barbiturate dependence center on sleep habits, stress management, substance mixing, and how people access or control medications. Choices around alcohol, sleep timing, and dose control can accelerate tolerance and withdrawal cycles. Exercise and steady routines can reduce reliance on sedatives, while chaotic routines can increase it.
Using barbiturates to fall asleep can reinforce reliance on them rather than on healthy sleep habits. Over time, this pattern builds tolerance and withdrawal-driven use.
Reaching for barbiturates to numb stress or anxiety makes the drug a primary coping tool. This increases the frequency and dose of use, fueling dependence.
Drinking alcohol with barbiturates intensifies sedation and amnesia, making the experience more reinforcing. This pairing increases cravings and accelerates tolerance.
Using benzodiazepines, opioids, or antihistamines alongside barbiturates normalizes sedative use. This stacking raises overdose risk and deepens dependence cycles.
Risk prevention
Reducing the chances of Barbiturate dependence involves careful use, close monitoring, and planning alternatives whenever possible. Prevention is about lowering risk, not eliminating it completely. Avoid mixing with other sedatives or alcohol, and get help early if sleep or anxiety symptoms feel unmanageable without pills.
Use barbiturates only when clearly needed and at the lowest effective dose. Regularly reassess whether the medicine still helps or can be stopped.
Keep treatment time-limited to lower the chance of Barbiturate dependence. Set a clear stop date and stick to it.
Combining barbiturates with alcohol, opioids, or other sedatives raises overdose and Barbiturate dependence risk. Always check before adding any new medicine or supplement.
Try non-drug sleep and anxiety strategies first, like CBT for insomnia or relaxation training. If medicine is needed, ask about options with lower dependence risk.
Transmission
Barbiturate dependence is not infectious—it doesn’t spread from person to person through touch, air, sex, or blood. Dependence develops through repeated exposure to barbiturates, often from long-term or high-dose prescriptions that escalate, medicines shared or taken without a prescription, or use alongside alcohol or other sedatives. Risk can cluster in families because of inherited vulnerability and shared habits, but there is no direct transmission like there is with a virus, and barbiturate dependence is not “caught” from someone else. Community and healthcare factors play a role too: easier access to barbiturates and limited monitoring can raise risk, while careful prescribing, safe storage, and getting help for early signs of barbiturate dependence can lower it.
When to test your genes
Consider genetic testing if you have strong family history of substance use disorders, unusually intense reactions to barbiturates or anesthesia, or severe side effects at typical doses. Testing may help tailor dosing, flag drug–drug risks, or guide safer alternatives. Always decide with a clinician or genetic counselor.
Diagnosis
You might notice small changes in daily routines—needing higher doses to get the same calm or sleep, running out of pills early, or feeling unwell between doses. For many, these patterns and their impact on work, school, or relationships prompt a closer look. Getting a diagnosis is often a turning point toward answers and support. Doctors use a stepwise approach to the diagnosis of Barbiturate dependence, focusing on current use, health risks, and safer next steps.
Your provider asks about what you take, how much, how often, and why. They also review tolerance, cravings, and attempts to cut down.
Questions cover sleep, mood, memory, driving, and work or school performance. This helps gauge how Barbiturate dependence is affecting day-to-day function.
Doctors review prescriptions, refills, and over-the-counter or online sources. With your consent, they may check pharmacy databases to spot early refills or multiple prescribers.
The exam looks for drowsiness, slowed thinking, slurred speech, or poor coordination. Vital signs may show low blood pressure or slowed breathing in recent use.
Stages of Barbiturate dependence
Barbiturate dependence does not have defined progression stages. Patterns can vary widely—some people take these medicines regularly, others in bursts—and it’s identified by current symptoms and how use affects daily life rather than a predictable step-by-step decline. Doctors usually start with a conversation about your medicine use, including any early symptoms of barbiturate dependence. Evaluation may include your health history, checking for withdrawal or oversedation, a physical exam, and sometimes blood or urine tests to confirm barbiturate use and monitor safety.
Outlook and prognosis
Looking at the long-term picture can be helpful. People with barbiturate dependence often wonder how recovery unfolds day to day—sleep may be disrupted at first, mood can swing, and concentration may dip. Many people ask, “What does this mean for my future?”, especially if work, driving, or caregiving are on the line. The risk that needs the most attention is overdose and slowed breathing, particularly when barbiturates are mixed with alcohol, opioids, or certain anxiety meds; this is where most deaths occur. With the right support, the future can look safer and more stable, but it usually requires a structured plan.
Doctors call this the prognosis—a medical word for likely outcomes. Most people improve with a gradual, medically supervised taper, counseling, and relapse-prevention supports. Early symptoms of barbiturate dependence—like needing higher doses for the same effect, using to avoid withdrawal, or hiding use—tend to ease over weeks to months once a taper begins, while sleep and anxiety can take longer to settle. Relapse can happen, especially in the first year, but each attempt at treatment builds skills that reduce risks over time. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
Mortality is largely tied to accidental overdose, severe withdrawal (including seizures), and coexisting health issues such as lung or heart disease. When withdrawal is managed in a medical setting and mixing with other sedatives is avoided, the risk of life‑threatening events drops substantially. Support from friends and family can make staying on track easier—rides to appointments, help managing medicines, and encouragement during rough patches all add up. Talk with your doctor about what your personal outlook might look like, including a taper plan, safer-use counseling if you’re not ready to quit, and steps to protect breathing and sleep as you recover.
Long-term effects
Barbiturate dependence can lead to ongoing changes in thinking, mood, sleep, and physical health that may last for years. Overdose risk remains a concern, especially if doses rise over time or other sedatives like alcohol are used. Early symptoms of Barbiturate dependence can be subtle, but long-term effects often become more noticeable in day-to-day life. Long-term effects vary widely, and what one person experiences may be very different from someone else’s.
Problems with memory, attention, and processing speed can persist. Many notice slower thinking or trouble learning new information. These effects may partly improve after stopping, but not always fully.
Ongoing anxiety, low mood, or irritability can develop. These shifts may come and go or linger. They can be harder to spot when sedation masks how someone feels.
Long-term use can fragment sleep and reduce deep, restorative rest. When doses are lowered, rebound insomnia may appear. Daytime fatigue can follow.
The body often needs higher doses to get the same effect over time. This raises the chance of overdose and breathing problems. Risks climb further if alcohol or opioids are also used.
How is it to live with Barbiturate dependence?
Living with barbiturate dependence can feel like your days are organized around avoiding withdrawal and chasing short-lived relief, which can crowd out work, school, and relationships. People often struggle with memory lapses, slowed thinking, poor coordination, and mood changes, making driving, caregiving, and even simple errands feel risky or exhausting. Those around you may notice secrecy, missed plans, or irritability, and they may carry worry or burnout as they try to help. With structured support—medical detox, counseling, and safer coping tools—many reclaim steadier routines and rebuild trust at a pace that feels manageable.
Treatment and drugs
Treatment for barbiturate dependence focuses first on safety, because suddenly stopping these medicines can lead to serious withdrawal. In most cases, doctors recommend a medically supervised taper, slowly lowering the dose over days to weeks—sometimes by switching to a longer-acting barbiturate—to reduce the risk of seizures, confusion, and unstable vital signs. Medicines that ease symptoms are called supportive care, and may include fluids, sleep support, and treatments for anxiety or nausea during withdrawal; in some settings, specialists add carefully monitored alternatives to help bridge the taper. Beyond medication, other therapies such as cognitive behavioral therapy, relapse-prevention counseling, and support groups help people understand triggers, build coping skills, and maintain recovery. Treatment plans often combine several approaches, and ongoing follow-up lowers the risk of return to use and helps manage co-occurring issues like pain, anxiety, or depression.
Non-drug treatment
Barbiturate dependence can affect daily routines, relationships, and work, so care often starts with practical, non-drug strategies that rebuild structure and safety. Non-drug treatments often lay the foundation for recovery, helping people manage stress, cravings, and triggers. Understanding early symptoms of barbiturate dependence can help you and your care team tailor a plan before problems escalate. Treatment plans are individualized and may combine several approaches over time.
CBT helps you spot thought patterns and situations that drive use. You learn specific skills to handle cravings and mood swings. Over time, these skills become more automatic.
This counseling style strengthens your own reasons to change. It respects your pace while uncovering barriers and ambivalence. Many find it boosts commitment to a recovery plan.
Positive behaviors are reinforced with small, immediate rewards. This can improve attendance and healthy routines. It often works well alongside counseling.
Clear, practical information helps you understand how barbiturates affect sleep, memory, and stress. You learn what triggers look like and how relapse happens. Knowledge makes day-to-day choices easier.
Your genes may have an impact on how drugs work for you
Genes can change how quickly your body breaks down barbiturates and how strongly your brain’s receptors respond, which affects dose needs, side effects, and overdose risk. Because of this, care teams often start low, go slow, and tailor taper plans.
Pharmacological treatments
Treatment for barbiturate dependence focuses on a safe, gradual withdrawal while preventing seizures and severe agitation. Phenobarbital is the most used medicine for tapering, with diazepam sometimes used as an alternative in select cases. Other medicines can ease nausea, tremor, fast heart rate, and sleep disruption during the taper. Not everyone responds to the same medication in the same way, so plans are closely tailored; if early symptoms of barbiturate dependence or withdrawal appear, treatment is safest under medical supervision.
Doctors often switch to long-acting phenobarbital and slowly reduce the dose over days to weeks. This helps prevent seizures and delirium while easing withdrawal symptoms. It’s usually done in hospital or closely supervised care.
Long-acting diazepam may be used if phenobarbital isn’t appropriate or available. It can steady withdrawal but needs careful monitoring for drowsiness and breathing problems.
Clonidine can reduce a racing heart, sweating, and blood pressure spikes. It does not prevent seizures, so it’s used alongside a phenobarbital or diazepam taper.
Propranolol may calm tremor, jitters, and fast heart rate. It isn’t a seizure medicine and isn’t used alone for withdrawal.
Genetic influences
If barbiturates have always hit you harder than friends—or you seem to need more pills to get the same calm—biology may be part of why dependence can develop. People sometimes ask about the genetic risk for barbiturate dependence, and studies suggest that inherited factors make up a sizable slice of overall risk for substance use disorders. Family history is one of the strongest clues to a genetic influence. Genes that tune the brain’s calming signals (often called GABA) and genes that control how fast your body breaks down barbiturates can change how the drug feels and how long it lasts. Those differences can raise the chance of stronger reward, quicker tolerance, or tougher withdrawal, all of which can fuel ongoing use. Even so, genes are only one part of the picture—prescribing patterns, stress, trauma, mental health, and support networks heavily influence who develops dependence and who doesn’t.
Is Barbiturate dependence genetic?
Genetics plays a modest role in barbiturate dependence. Variations in genes affecting brain receptors and drug metabolism can raise or lower risk, tolerance, and withdrawal severity. Still, environment, mental health, and exposure usually drive most vulnerability.
Pharmacogenetics—how genetics influence drug effects
During treatment for Barbiturate dependence, many people start a supervised taper with a long-acting barbiturate such as phenobarbital, and genetics can affect how smoothly that taper goes. Genes can influence how quickly you clear phenobarbital, which can change the dose you need and how often it’s given. Differences in liver enzyme activity—linked to genes like CYP2C9 and CYP2C19—may mean the medicine leaves your body more slowly (raising the risk of oversedation) or more quickly (risking breakthrough withdrawal), so your care team may adjust the dose, taper pace, and monitoring. Because barbiturates can also speed up the liver’s handling of other medicines, genetic variation and drug interactions are often considered together when planning care. Genes are only one part of the picture; age, liver health, and other medicines play a major role, and formal genetic testing isn’t routinely needed for Barbiturate dependence. When responses are unexpected—such as unusual drowsiness at low doses or withdrawal despite standard dosing—exploring the pharmacogenetics of barbiturate dependence with targeted testing may help tailor the taper and improve safety.
Interactions with other conditions
When Barbiturate dependence coexists with alcohol use disorder, opioid therapy, or benzodiazepine use, their sedating effects stack, raising the chance of slowed breathing, confusion, falls, and overdose. People with chronic lung or sleep conditions—such as COPD, asthma, or sleep apnea—face even higher risks because these drugs can further suppress nighttime breathing. Barbiturate dependence also overlaps with mood and anxiety disorders; while symptoms may feel briefly quieter after a dose, depression, irritability, and suicidal thoughts can worsen over time. Doctors call it a “comorbidity” when two conditions occur together, and this matters for safety because medicines for one issue can trigger problems in the other. For example, someone taking opioid pain medicines or gabapentin for nerve pain may become excessively drowsy when Barbiturate dependence is present, and seizure disorders need special planning because withdrawal can provoke seizures. Liver disease can change how barbiturates are broken down, causing stronger or longer-lasting effects; older adults are especially vulnerable to confusion and falls. In clinics, early symptoms of Barbiturate dependence may be overlooked in people being treated for anxiety or insomnia, which can complicate care plans and recovery.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden “sleeping” medicines that quieted pain and worry but sometimes led to powerful cravings and withdrawal. In the early 20th century, barbiturates became common for anxiety, insomnia, and seizures. Many found relief; others discovered that stopping suddenly brought shaking, sleeplessness, and in severe cases, confusion or seizures. Doctors saw patterns: a rising need for higher doses, time spent seeking refills, and life narrowing around the next tablet. Families noticed bottles hidden in handbags or nightstands, and mornings shaped by whether a dose was taken overnight. From early theories to modern research, the story of barbiturate dependence shows how medical practice and public health have evolved together.
First described in the medical literature as “habit formation” from sedative-hypnotics, barbiturate dependence caught attention after World War II, when these drugs were widely prescribed. Early warnings came from hospital wards where abrupt discontinuation caused dangerous withdrawal, prompting guarded tapers rather than quick stops. By the 1960s and 1970s, reports linked higher-potency, short-acting barbiturates with stronger dependence risks. This led clinicians to favor longer-acting versions when needed, and to limit total quantities. Regulatory shifts followed in the United States and Europe, tightening controls and encouraging safer prescribing.
With the arrival of benzodiazepines and later sleep medicines, barbiturates were used less for common anxiety or insomnia. Yet dependence did not disappear. People living with epilepsy or severe headaches, and those with chronic pain or multiple prescriptions, sometimes remained exposed. Public health campaigns and addiction medicine programs introduced structured tapers, careful monitoring, and support services, treating barbiturate dependence as a medical condition rather than a moral failing.
In recent decades, knowledge has built on a long tradition of observation. Clinicians recognized that not everyone develops dependence, and risk differs by dose, speed of onset, other substances used, and personal factors like past substance use or mental health conditions. Toxicology and emergency medicine refined protocols to manage overdoses and prevent complications, while outpatient care emphasized slow dose reductions, counseling, and relapse prevention. International guidelines began to align on cautious prescribing and patient education.
Today, barbiturate dependence is less common than in its mid‑century peak but remains clinically important. Early symptoms of barbiturate dependence may still be missed when multiple medicines are involved or when sedating effects are attributed to stress or poor sleep. Awareness of past misunderstandings can help people and clinicians spot warning signs sooner, plan safer tapers, and choose alternatives when possible. The historical arc—initial enthusiasm, recognition of harms, regulatory change, and compassionate, evidence‑based care—continues to inform how barbiturates are prescribed and how dependence is treated.